Chargement en cours...
Effectiveness of lomustine and bevacizumab in progressive glioblastoma: a meta-analysis
BACKGROUND: Glioblastomas (GBMs) are the most aggressive type of glial brain tumors. Despite aggressive treatment with surgery and chemoradiation, GBMs invariably relapse and tumors are progressive. Controversy remains on optimal treatment of patients with recurrent GBMs. Data from previous trials h...
Enregistré dans:
| Publié dans: | Onco Targets Ther |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6005326/ https://ncbi.nlm.nih.gov/pubmed/29942135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S160685 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|